Clinical Trial Update: Efficacy of Misoprostol in Prevention of Neonatal Respiratory Morbidity in Parturient at Early Term Elective Caesarian Section [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating misoprostol for preventing neonatal respiratory morbidity in newborns after early term elective cesarean section; current st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Respiratory Distress
• Transient Tachypnea of the Newborn

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Ain Shams University | Conditions: Transient Tachypnea of the Newborn, Neonatal Respiratory Distress | Phase 3 | Status: UNKNOWN